Announcements Trials
Browse Landscape

Phase

Phase 1 75Phase 1/2 30Phase NA 28Phase 2 23Phase 3 6Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 24Breast 3Other 2Gastrointestinal 2Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 103Carcinoma, Renal Cell 30Urinary Bladder Neoplasms 22Breast Neoplasms 20Carcinoma, Transitional Cell 11Lung Neoplasms 10Melanoma 9Neoplasms 8Kidney Neoplasms 8Neoplasm Metastasis 7Colonic Neoplasms 7Sarcoma 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Metastatic Castration-resistant Prostate Cancer 6Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Brain Neoplasms 4Osteosarcoma 3Diabetes Mellitus 3Colorectal Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Hepatocellular 3Urologic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Endometrial Neoplasms × Genitourinary × Clear all
NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Mayo Clinic

Phase EARLY_PHASE1 Completed
2 enrolled
BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡